ID   FM3.D
AC   CVCL_UI31
SY   FM3D; FM3.Differentiated
DR   Cosmic; 1132578
DR   Wikidata; Q93555035
RX   PubMed=8665567;
RX   PubMed=9688544;
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2046 ! FM3
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
RX   PubMed=8665567; DOI=10.1007/s002620050272;
RA   Kirkin A.F., thor Straten P., Zeuthen J.;
RT   "Differential modulation by interferon gamma of the sensitivity of
RT   human melanoma cells to cytolytic T cell clones that recognize
RT   differentiation or progression antigens.";
RL   Cancer Immunol. Immunother. 42:203-212(1996).
//
RX   PubMed=9688544; DOI=10.1016/S0014-5793(98)00603-6;
RA   Dzhandzhugazyan K.N., Kirkin A.F., thor Straten P., Zeuthen J.;
RT   "Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated
RT   human melanomas.";
RL   FEBS Lett. 430:227-230(1998).
//